Primary regulatory
EMEA-003258-PIP02-23: retatrutide paediatric investigation plan.
European Medicines Agency. EMEA-003258-PIP02-23: retatrutide paediatric investigation plan. Decision P/0336/2024, 2024-09-13.
European Medicines AgencyPublished Sep 13, 2024Accessed Jul 12, 2026
Registry record
Source metadata
- Publisher
- European Medicines Agency
- Source type
- Primary regulatory
- Registry ID
research-reta-08- Source code
- RETA-08
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.